CRP and neoplasm: A succession of studies confirmed that patients with a high level of preoperative C‐reactive protein (CRP) (pre‐CRP) were closely related to a poor prognosis for GC,11, 12 indicating that pre‐CRP is expected to become an effective forecasting tool alone or in combination with other tumor characteristics or inflammation indices to predict the prognosis of GC.